Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the ...
It’s now just a bit over two weeks into Donald Trump’s second term, and to the delight of my friends on the right and the ...
I've often been wondering if I was the one who suffered cognitive damage and the Republican really won the Pennsylvania ...